Latest News & Updates
Breaking News
2 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Zentalis Pharmaceuticals Advances Azenosertib Toward FDA Accelerated Approval With Pivotal Dose Selection
Zentalis selects pivotal dose for azenosertib and initiates Phase 3 confirmatory trial, targeting FDA accelerated approval in Cyclin E1-positive PROC.
Pharma Now Editorial Team
Recordati Achieves Phase 2 Primary Endpoint for Pasireotide in Post-Bariatric Hypoglycemia Ahead of FDA Meeting
Recordati meets Phase 2 primary endpoint for pasireotide in post-bariatric hypoglycemia; FDA meeting scheduled as Q1 revenue rises 4.9% to €713.4M.
Pharma Now Editorial Team
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
6th Drug Safety Symposium 2026 in Mumbai addresses real-world pharmacovigilance impact, regulatory challenges, and signal prioritization for 100+ senior PV leaders.
Team Pharma Now
Achieve Life Sciences Appoints Three Verona Pharma Commercial Veterans Ahead of Cytisinicline FDA Review
Achieve Life Sciences reunites the Ohtuvayre launch team ahead of an FDA decision on cytisinicline, backed by a $354M milestone-linked financing structure.
Pharma Now Editorial Team
